| Filing date | Description | Form | View |
|---|---|---|---|
Statement of changes in beneficial ownership of securities |
4 | View HTML | |
Statement of changes in beneficial ownership of securities |
4 | View HTML | |
Statement of changes in beneficial ownership of securities |
4 | View HTML | |
Statement of changes in beneficial ownership of securities |
4 | View HTML | |
Statement of changes in beneficial ownership of securities |
4 | View HTML | |
Statement of changes in beneficial ownership of securities |
4 | View HTML | |
Statement of changes in beneficial ownership of securities |
4 | View HTML | |
Statement of changes in beneficial ownership of securities |
4 | View HTML | |
Statement of changes in beneficial ownership of securities |
4 | View HTML | |
Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3 |
424B5 | View HTML |
Data provided by Kaleidoscope.
2022
2021
2020
Thursday, May 6, 2021 at 9:00 a.m. Pacific Time
The 2021 Annual Meeting of Stockholders of Nurix Therapeutics, Inc. (“Nurix” or the “Company”) was held on Thursday, May 6, 2021.
Stockholders of record of Nurix common stock as of the close of business on March 12, 2021 were entitled to vote at the meeting. A replay of the webcast of the meeting will be accessible by visiting www.virtualshareholdermeeting.com/NRIX2021 .
'